J.P. Turner & Co Capital Management’s VanEck Biotech ETF BBH Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,854	Closed	-$250K	–	187
2015 Q2	$250K	Buy	1,854 +70	+4%	+$9.3K	0.19%	169
2015 Q1	$232K	Buy	1,784 +36	+2%	+$4.52K	0.21%	149
2014 Q4	$202K	Buy	+1,748	New	+$197K	0.2%	166

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

VFAM

Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

LFM

Lumina Fund Management New York $164M AUM 27.72% 1-Year Est. Return

J.P. Turner & Co Capital Management's BBH Position: Q3 2015 in Review

J.P. Turner & Co Capital Management sold out of VanEck Biotech ETF (BBH) in Q3 2015, closing a stake of 1,854 shares — an estimated $250K sold.

J.P. Turner & Co Capital Management first reported a position in BBH in Q4 2014 and held it in 3 quarters. The position peaked at $250K in Q2 2015. 83 funds tracked by Wall St. Rank hold BBH as of Q3 2015.

J.P. Turner & Co Capital Management reported no remaining VanEck Biotech ETF position as of Q3 2015 after selling out during the quarter.
J.P. Turner & Co Capital Management sold 1,854 VanEck Biotech ETF shares in Q3 2015, an estimated $250K.
J.P. Turner & Co Capital Management first reported a position in VanEck Biotech ETF in Q4 2014 and held it in 3 quarters.
J.P. Turner & Co Capital Management's VanEck Biotech ETF position peaked at $250K in Q2 2015.
83 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.